Quarterly report · Q3
7716.TEDINET S100PL20
Period2022-01-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥36.1bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥33.5bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥11.9bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥11.1bn | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥14.7bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.3bn | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥14.4bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥11.3bn | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.2bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.1bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥10.2bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥8.1bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥100.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥94.5bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥90.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥11.5bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥90.7bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥82.9bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥81.6bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥35.3bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥36.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥118.92 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.41 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥93.45 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.51 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥118.63 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥93.24 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 89.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.4% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥3.4bn |
| jpcrp040300-q3r_E02331-000Dental Productsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E02331-000Dental Productsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E02331-000Dental Productsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥12.7bn |
| jpcrp040300-q3r_E02331-000Industrial Productsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q3r_E02331-000Industrial Productsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q3r_E02331-000Industrial Productsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q3r_E02331-000Surgical Productsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E02331-000Surgical Productsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E02331-000Surgical Productsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.2bn |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥36.1bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥36.1bn |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥15.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥3.1bn |
| jpcrp040300-q3r_E02331-000Dental Productsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥28.7bn |
| jpcrp040300-q3r_E02331-000Dental Productsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥28.7bn |
| jpcrp040300-q3r_E02331-000Dental Productsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥12.2bn |
| jpcrp040300-q3r_E02331-000Industrial Productsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E02331-000Industrial Productsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E02331-000Industrial Productsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥1.0bn |
| jpcrp040300-q3r_E02331-000Surgical Productsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.0bn |
| jpcrp040300-q3r_E02331-000Surgical Productsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.0bn |
| jpcrp040300-q3r_E02331-000Surgical Productsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥1.0bn |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥33.5bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥33.5bn |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥14.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 386
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | 2747397000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 33469106000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 33469106000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | 28679079000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | 2042629000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | 2747397000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 33469106000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 33469106000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | 12177407000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | 1020082000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | 1023696000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 14221187000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -3107418000 | JPY |
| Operating income | Prior1YTDDuration | 11113769000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | 30301499000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | 2393080000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | 3405627000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 36100208000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 36100208000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | 30301499000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | 2393080000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | 3405627000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 36100208000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 36100208000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02331-000DentalProductsReportableSegmentsMember | 12727332000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02331-000SurgicalProductsReportableSegmentsMember | 1233333000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E02331-000IndustrialProductsReportableSegmentsMember | 1310459000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 15271125000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -3377096000 | JPY |
| Operating income | CurrentYTDDuration | 11894028000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-14 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |